Back to GetFilings.com



 

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED: DECEMBER 31, 2003

 

COMMISSION FILE NUMBER:  1-15587

 

MED DIVERSIFIED, INC.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

NEVADA

 

84-1037630

(STATE OR OTHER JURISDICTION OF
INCORPORATION OR ORGANIZATION)

 

(I.R.S. EMPLOYER
IDENTIFICATION NO.)

 

 

 

100 BRICKSTONE SQUARE, FIFTH FLOOR, ANDOVER, MA 01810

(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)

 

 

 

(978) 323-2500

(ISSUER’S TELEPHONE NUMBER)

 

 

 

MED DIVERSIFIED, INC.

100 Brickstone Square, Fifth Floor

Andover, MA 01810

 

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o

 

Indicate by check mark whether the issuer is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).  Yes o No ý

 

Indicate by check mark whether the issuer has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.  Yes ý No o

 

As of January 30, 2004, 148,661,526 shares of the registrant’s common stock, $0.001 par value per share, were outstanding.

 

 



 

Explanatory Note

 

As more fully explained in Part II, Item 5 of the quarterly report on Form 10-Q we filed on November 19, 2003 for the three and six months ended September 30, 2003, in October 2003 we formally requested permission from the Securities and Exchange Commission (the “SEC”) to use modified reporting procedures under the Securities Exchange Act of 1934.  We deferred the review of our financial statements filed as part of that quarterly report by our independent accountants, Brown & Brown, LLP (“Brown & Brown”), while our request was pending.

 

The SEC informally indicated to us that we could not use modified reporting procedures. Brown and Brown will commence its review of the Form 10-Q for the three and six months ended September 30, 2003, and for the three and nine months ended December 31, 2003, on April 1, 2004 or earlier, if practicable. At the completion of Brown & Brown’s reviews, we plan to file a Form 8-K to report the completion of the Brown & Brown reviews if those reviews do not result in any material adjustments to our unaudited financial statements, or one or more amended quarterly reports on Form 10-Q/A if any material adjustments are required.

 

INDEX

 

 

 

Page

PART I.

FINANCIAL INFORMATION

3

 

 

 

 

Item 1.  Financial Statements.

3

 

Condensed Consolidated Balance Sheets at December 31, 2003 (unaudited) and March 31, 2003

3

 

Condensed Consolidated Statements of Operations for the Three Months ended December 31, 2003 and 2002 (unaudited)

4

 

Condensed Consolidated Statements of Operations for the Nine Months ended December 31, 2003 and 2002 (unaudited)

5

 

Condensed Consolidated Statements of Cash Flows for the Nine Months ended December 31, 2003 and 2002 (unaudited)

6

 

Notes to the Condensed Consolidated Financial Statements at December 31, 2003 (unaudited)

7

 

 

 

 

Item 2.  Management’s Discussion and Analysis of Financial Condition and Results of Operations.

27

 

 

 

 

Item 3.  Quantitative and Qualitative Disclosures About Market Risk.

32

 

 

 

 

Item 4.  Controls and Procedures.

32

 

 

 

PART II.

OTHER INFORMATION

33

 

 

 

 

Item 1.  Legal Proceedings.

33

 

 

 

 

Item 2.  Changes in Securities.

35

 

 

 

 

Item 3.  Defaults Upon Senior Securities.

35

 

 

 

 

Item 4.  Submission of Matters to a Vote of Security Holders.

35

 

 

 

 

Item 5.  Other Information.

35

 

 

 

 

Item 6.  Exhibits and Reports on Form 8-K.

36

 

 

 

SIGNATURES

37

 

2



 

PART I.  FINANCIAL INFORMATION

 

ITEM 1.  FINANCIAL STATEMENTS.

 

MED DIVERSIFIED, INC.

(Debtor-In-Possession as of November 27, 2002)

Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

December 31, 2003

 

March 31, 2003

 

 

 

(unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

21,989

 

$

10,072

 

Accounts receivable, net of allowances of $20,637 and $26,209 at December 31, 2003 and March 31, 2003, respectively

 

29,949

 

36,594

 

Accounts receivable from affiliates, net

 

98

 

186

 

Prepayments and other current assets

 

7,744

 

7,847

 

Assets of discontinued operations

 

3,244

 

891

 

Total current assets

 

63,024

 

55,590

 

Non-current assets:

 

 

 

 

 

Property and equipment, net

 

10,983

 

13,856

 

Goodwill

 

20,840

 

20,548

 

Investments

 

10,357

 

11,231

 

Other intangibles, net

 

31,448

 

32,042

 

Assets of discontinued operations, net of current portion

 

 

3,105

 

Other assets

 

1,816

 

1,887

 

Total non-current assets

 

75,444

 

82,669

 

TOTAL ASSETS

 

$

138,468

 

$

138,259

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

7,859

 

$

5,848

 

Accrued salaries and benefit costs

 

15,338

 

14,700

 

Accrued liabilities

 

9,494

 

8,886

 

Liabilities of discontinued operations

 

12,127

 

11,716

 

Current maturities of capital leases

 

1,231

 

10

 

Liabilities subject to compromise (Note 3)

 

345,785

 

 

Total current liabilities

 

391,834

 

41,160

 

Long-Term liabilities:

 

 

 

 

 

Liabilities subject to compromise (Note 3)

 

 

356,873

 

Capital leases

 

12

 

20

 

Other liabilities

 

 

 

Liabilities of discontinued operations, net of current portion

 

 

1,852

 

Total long-term liabilities

 

12

 

358,745

 

Minority interest

 

423

 

377

 

Stockholders’ equity (deficit):

 

 

 

 

 

Series A convertible preferred stock, 5,000 authorized, none issued or outstanding at December 31, 2003 and March 31, 2003

 

 

 

Common shares, $0.001 par value, 400,000 shares authorized at December 31, 2003 and March 31, 2003, 148,662 issued and outstanding at December 31, 2003 and March 31, 2003

 

149

 

149

 

Paid in capital

 

427,179

 

427,179

 

Stock subscription

 

(4,400

)

(4,400

)

Common stock options

 

377

 

377

 

Deferred compensation

 

 

(63

)

Accumulated deficit

 

(675,737

)

(683,896

)

Accumulated other comprehensive income

 

(3

)

(3

)

Less: treasury shares at cost, 460 shares at December 31, 2003 and March 31, 2003

 

(1,366

)

(1,366

)

Total stockholders’ deficit

 

(253,801

)

(262,023

)

TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

$

138,468

 

$

138,259

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3



 

MED DIVERSIFIED, INC.

(Debtor-In-Possession as of November 27, 2002)

Condensed Consolidated Statements of Operations

For the Three Months Ended December 31, 2003 and 2002

(unaudited, in thousands, except for per share information)

 

 

 

2003

 

2002

 

NET REVENUE:

 

 

 

 

 

Non affiliates

 

$

87,847

 

$

88,972

 

Affiliates

 

111

 

195

 

Total net revenue

 

87,958

 

89,167

 

 

 

 

 

 

 

COSTS AND EXPENSES:

 

 

 

 

 

Cost of services

 

47,401

 

51,103

 

Selling, general and administrative

 

34,956

 

36,392

 

Depreciation and amortization

 

1,348

 

1,509

 

Total costs and expenses

 

83,705